SCHEMBL6235341

SCHEMBL6235341

c1ccc(Nc2ncnc3n[nH]c(-c4ccccc4)c23)cc1

nearest known ligand 0.77

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EGFR P00533 11/20 0.77
ABL1 P00519 9/20 0.77
CDK1 P06493 5/20 0.77
SRC P12931 8/20 0.69
PRKCA P17252 6/20 0.69
PIK3CD O00329 6/20 0.60
PIK3CA P42336 6/20 0.60
PIK3CB P42338 6/20 0.60
PIK3CG P48736 6/20 0.60
PRKDC P78527 6/20 0.60
MKNK1 Q9BUB5 1/20 0.53
GSK3B P49841 1/20 0.51
PDGFRB P09619 1/20 0.50
PDGFRA P16234 1/20 0.50
MAPK1 P28482 1/20 0.49
NUDT14 O95848 1/20 0.48
NUDT5 Q9UKK9 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6686760 0.91 EGFR (0.76) EGFRABL1CDK1SRCPRKCA
SCHEMBL6689658 0.87 EGFR (0.70) EGFRABL1CDK1SRCPRKCA
SCHEMBL8327348 0.75 PIK3CD (0.67) EGFRABL1CDK1SRCPIK3CD
SCHEMBL8326897 0.75 PIK3CD (1.00) EGFRABL1SRCPIK3CDPIK3CA
SCHEMBL6235344 0.75 EGFR (0.55) EGFRABL1CDK1SRCPRKCA
SCHEMBL8117270 0.73 EGFR (0.60) EGFRABL1CDK1SRCPRKCA
SCHEMBL30387566 0.73 PIK3CD (1.00) EGFRABL1SRCPIK3CDPIK3CA
SCHEMBL18797649 0.72 EGFR (0.59) EGFRABL1CDK1SRCPRKCA
SCHEMBL9820109 0.71 RPS6KA3 (0.66) EGFRABL1CDK1GSK3BPDGFRB
SCHEMBL21807006 0.70 EGFR (0.56) EGFRABL1CDK1SRCPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0836613-B1 WATER-SOLUBLE ADENOSINE KINASE INHIBITORS METABASIS THERAPEUTICS INC (US) 2005-05-25 EP disclosed
EP-0832092-B1 ORALLY ACTIVE ADENOSINE KINASE INHIBITORS METABASIS THERAPEUTICS INC (US) 2004-11-17 EP disclosed
EP-0496617-B1 Adenosine kinase inhibitors METABASIS THERAPEUTICS INC (US) 1999-12-01 EP disclosed
EP-0836613-A1 WATER-SOLUBLE ADENOSINE KINASE INHIBITORS GENSIA, INC. (US) 1998-04-22 EP disclosed
EP-0832092-A1 ORALLY ACTIVE ADENOSINE KINASE INHIBITORS GENSIA, INC. (US) 1998-04-01 EP disclosed
EP-0682519-A4 ADENOSINE KINASE INHIBITORS. GENSIA INC (US) 1997-12-17 EP disclosed
US-5646128-A TREATING INFLAMMATION, SEPSIS, SEPTIC SHOCK, BURNS GENSIA, INC. (US) 1997-07-08 US disclosed
WO-1996040706-A1 ORALLY ACTIVE ADENOSINE KINASE INHIBITORS GENSIA-SICOR (US) 1996-12-19 WO disclosed
WO-1996040707-A1 WATER-SOLUBLE ADENOSINE KINASE INHIBITORS GENSIA SICOR (US) 1996-12-19 WO disclosed
US-5506347-A ADENOSINE KINASE INHIBITOR GENSIA, INC. (US) 1996-04-09 US disclosed
EP-0682519-A1 ADENOSINE KINASE INHIBITORS GENSIA, INC. (US) 1995-11-22 EP disclosed
WO-1994017803-A9 ADENOSINE KINASE INHIBITORS 1994-09-29 WO disclosed
WO-1994017803-A1 ADENOSINE KINASE INHIBITORS GENSIA, INC. (US) 1994-08-18 WO disclosed
WO-1992012718-A1 ADENOSINE KINASE INHIBITORS GENSIA, INC. (US) 1992-08-06 WO disclosed
EP-0496617-A1 Adenosine kinase inhibitors GENSIA, INC. (US) 1992-07-29 EP disclosed